Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 2 | 2023 | 114 | 1.350 |
Why?
|
| Coronary Artery Bypass | 14 | 2017 | 111 | 1.140 |
Why?
|
| Thoracoscopy | 2 | 2018 | 12 | 1.060 |
Why?
|
| Atrial Fibrillation | 4 | 2020 | 396 | 0.930 |
Why?
|
| Propofol | 2 | 2022 | 20 | 0.840 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 10 | 0.820 |
Why?
|
| Atrial Flutter | 1 | 2023 | 20 | 0.820 |
Why?
|
| Hemodynamics | 15 | 2023 | 162 | 0.800 |
Why?
|
| Methohexital | 1 | 2022 | 5 | 0.760 |
Why?
|
| Vasoconstriction | 1 | 2022 | 43 | 0.760 |
Why?
|
| Humans | 56 | 2023 | 32952 | 0.690 |
Why?
|
| Intubation, Intratracheal | 3 | 2017 | 74 | 0.670 |
Why?
|
| Goals | 1 | 2020 | 35 | 0.640 |
Why?
|
| Bronchoscopy | 2 | 2017 | 47 | 0.590 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 85 | 0.580 |
Why?
|
| Prospective Studies | 12 | 2023 | 2338 | 0.580 |
Why?
|
| Cardiology | 1 | 2019 | 108 | 0.560 |
Why?
|
| Stents | 2 | 2008 | 174 | 0.510 |
Why?
|
| Bronchi | 1 | 2017 | 34 | 0.510 |
Why?
|
| Postoperative Complications | 6 | 2017 | 828 | 0.490 |
Why?
|
| Cardiotonic Agents | 9 | 2006 | 43 | 0.460 |
Why?
|
| Collateral Circulation | 1 | 2015 | 9 | 0.450 |
Why?
|
| Coronary Circulation | 1 | 2015 | 40 | 0.450 |
Why?
|
| Coronary Thrombosis | 3 | 2009 | 14 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2011 | 81 | 0.420 |
Why?
|
| Blood Loss, Surgical | 2 | 2011 | 54 | 0.410 |
Why?
|
| Heart Failure | 2 | 2020 | 761 | 0.410 |
Why?
|
| Myocardial Ischemia | 5 | 2002 | 105 | 0.370 |
Why?
|
| Coronary Vessels | 2 | 2015 | 164 | 0.360 |
Why?
|
| Pulmonary Atelectasis | 1 | 2011 | 2 | 0.350 |
Why?
|
| Epinephrine | 7 | 1998 | 42 | 0.350 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 416 | 0.350 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 6 | 0.350 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 16 | 0.350 |
Why?
|
| Mediastinal Neoplasms | 1 | 2011 | 13 | 0.350 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2007 | 56 | 0.340 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 59 | 0.340 |
Why?
|
| Male | 35 | 2023 | 19743 | 0.320 |
Why?
|
| Amrinone | 5 | 1998 | 5 | 0.320 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 541 | 0.290 |
Why?
|
| Anesthesia | 4 | 2011 | 64 | 0.280 |
Why?
|
| Middle Aged | 28 | 2017 | 12202 | 0.280 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 1999 | 63 | 0.280 |
Why?
|
| Oxygen | 4 | 2020 | 144 | 0.280 |
Why?
|
| Risk Factors | 5 | 2020 | 4001 | 0.280 |
Why?
|
| Perioperative Care | 1 | 2008 | 56 | 0.280 |
Why?
|
| Heart Rate | 11 | 2007 | 345 | 0.270 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 78 | 0.270 |
Why?
|
| Dobutamine | 5 | 1998 | 55 | 0.260 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 61 | 0.260 |
Why?
|
| Electric Countershock | 2 | 2022 | 17 | 0.250 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 4057 | 0.250 |
Why?
|
| Female | 31 | 2017 | 20363 | 0.220 |
Why?
|
| Dopamine | 3 | 2006 | 234 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 180 | 0.210 |
Why?
|
| Positive-Pressure Respiration | 1 | 2023 | 13 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 196 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 231 | 0.200 |
Why?
|
| Pulmonary Circulation | 1 | 2022 | 4 | 0.190 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 240 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 298 | 0.190 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2002 | 4 | 0.190 |
Why?
|
| Fentanyl | 5 | 1991 | 32 | 0.180 |
Why?
|
| Postoperative Care | 2 | 2007 | 78 | 0.180 |
Why?
|
| Propanolamines | 2 | 1999 | 11 | 0.170 |
Why?
|
| Postoperative Period | 3 | 2017 | 99 | 0.170 |
Why?
|
| Aged | 17 | 2017 | 10624 | 0.170 |
Why?
|
| Lung | 1 | 2022 | 268 | 0.170 |
Why?
|
| Nitroglycerin | 1 | 2000 | 11 | 0.170 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1997 | 27 | 0.170 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 60 | 0.160 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2007 | 13 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2016 | 930 | 0.160 |
Why?
|
| Consensus | 1 | 2019 | 87 | 0.150 |
Why?
|
| Anesthetics | 2 | 1989 | 19 | 0.150 |
Why?
|
| Aorta | 1 | 2019 | 127 | 0.150 |
Why?
|
| Coronary Restenosis | 2 | 2008 | 13 | 0.140 |
Why?
|
| Isoproterenol | 2 | 1997 | 17 | 0.140 |
Why?
|
| Double-Blind Method | 8 | 2000 | 543 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2018 | 12 | 0.140 |
Why?
|
| Ischemia | 1 | 2018 | 104 | 0.140 |
Why?
|
| Calcium | 4 | 1992 | 323 | 0.140 |
Why?
|
| Cardiac Output, Low | 2 | 1994 | 10 | 0.140 |
Why?
|
| Tachycardia | 1 | 1997 | 6 | 0.140 |
Why?
|
| Premedication | 1 | 1997 | 16 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 1997 | 28 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1997 | 30 | 0.130 |
Why?
|
| Heart | 4 | 1995 | 185 | 0.130 |
Why?
|
| Pharyngitis | 1 | 2017 | 10 | 0.130 |
Why?
|
| Cardiac Output | 5 | 1995 | 34 | 0.130 |
Why?
|
| Preanesthetic Medication | 2 | 2002 | 3 | 0.120 |
Why?
|
| Mental Recall | 1 | 1996 | 51 | 0.120 |
Why?
|
| Random Allocation | 1 | 2017 | 229 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 1852 | 0.120 |
Why?
|
| Adult | 10 | 2017 | 9586 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1246 | 0.120 |
Why?
|
| Anesthesiology | 1 | 1996 | 48 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 193 | 0.120 |
Why?
|
| Bronchial Diseases | 1 | 1995 | 4 | 0.120 |
Why?
|
| Hemoptysis | 1 | 1995 | 3 | 0.120 |
Why?
|
| Hodgkin Disease | 2 | 2011 | 9 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 1996 | 187 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 1996 | 240 | 0.110 |
Why?
|
| Dopamine Agents | 1 | 1994 | 20 | 0.110 |
Why?
|
| Anesthesia, Inhalation | 2 | 2011 | 16 | 0.100 |
Why?
|
| Anesthesia, Intravenous | 3 | 1989 | 6 | 0.100 |
Why?
|
| Myocardial Infarction | 5 | 2000 | 486 | 0.090 |
Why?
|
| Hypertension | 2 | 1997 | 983 | 0.090 |
Why?
|
| Critical Illness | 1 | 1993 | 84 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3460 | 0.090 |
Why?
|
| Magnesium Sulfate | 2 | 1991 | 14 | 0.090 |
Why?
|
| Calcium Chloride | 1 | 1992 | 2 | 0.090 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.090 |
Why?
|
| Coronary Vasospasm | 1 | 1991 | 4 | 0.090 |
Why?
|
| Splanchnic Circulation | 1 | 2011 | 3 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 29 | 0.090 |
Why?
|
| Bradycardia | 1 | 2011 | 18 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 98 | 0.080 |
Why?
|
| Kidney | 1 | 1994 | 523 | 0.080 |
Why?
|
| Biopsy | 1 | 2011 | 245 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 1998 | 622 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 51 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2002 | 101 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 32 | 0.080 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 60 | 0.080 |
Why?
|
| Etomidate | 1 | 1989 | 5 | 0.080 |
Why?
|
| Drug Interactions | 4 | 1997 | 78 | 0.080 |
Why?
|
| Pentobarbital | 2 | 1988 | 4 | 0.070 |
Why?
|
| Heart Atria | 1 | 2009 | 79 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.070 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 14 | 0.070 |
Why?
|
| Anesthesia, Conduction | 1 | 2008 | 24 | 0.070 |
Why?
|
| Echocardiography | 1 | 2009 | 191 | 0.070 |
Why?
|
| Aspirin | 1 | 2008 | 62 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 44 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2016 | 880 | 0.070 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1988 | 5 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 85 | 0.070 |
Why?
|
| Medical Errors | 1 | 2007 | 37 | 0.070 |
Why?
|
| Cyclic AMP | 2 | 1998 | 45 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2006 | 48 | 0.060 |
Why?
|
| Blood Pressure | 6 | 2006 | 867 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2006 | 205 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 172 | 0.060 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 60 | 0.050 |
Why?
|
| Young Adult | 1 | 2011 | 2738 | 0.050 |
Why?
|
| Coronary Disease | 2 | 1997 | 217 | 0.050 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 6 | 0.050 |
Why?
|
| Sex Factors | 2 | 1996 | 681 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2006 | 33 | 0.050 |
Why?
|
| Age Factors | 3 | 1996 | 1202 | 0.040 |
Why?
|
| North Carolina | 1 | 2016 | 1550 | 0.040 |
Why?
|
| Time Factors | 5 | 2011 | 2195 | 0.040 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 1999 | 3 | 0.040 |
Why?
|
| Sufentanil | 2 | 1989 | 5 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 29 | 0.040 |
Why?
|
| Animals | 7 | 1997 | 7598 | 0.040 |
Why?
|
| Length of Stay | 2 | 1999 | 329 | 0.040 |
Why?
|
| Heparin | 2 | 1990 | 70 | 0.040 |
Why?
|
| Antioxidants | 1 | 1999 | 116 | 0.040 |
Why?
|
| Adrenergic Agonists | 1 | 1998 | 5 | 0.040 |
Why?
|
| Heart Valves | 1 | 1998 | 16 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1998 | 59 | 0.030 |
Why?
|
| Heart Conduction System | 2 | 1988 | 78 | 0.030 |
Why?
|
| Myocardium | 2 | 1997 | 192 | 0.030 |
Why?
|
| Renal Circulation | 1 | 1997 | 12 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1997 | 31 | 0.030 |
Why?
|
| Electrocardiography | 3 | 1999 | 637 | 0.030 |
Why?
|
| Nausea | 1 | 1997 | 52 | 0.030 |
Why?
|
| Chromonar | 1 | 1997 | 1 | 0.030 |
Why?
|
| Coumarins | 1 | 1997 | 1 | 0.030 |
Why?
|
| Myocardial Reperfusion | 1 | 1997 | 10 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1997 | 18 | 0.030 |
Why?
|
| Hospital-Patient Relations | 1 | 1996 | 3 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 1999 | 43 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 79 | 0.030 |
Why?
|
| Telephone | 1 | 1996 | 58 | 0.030 |
Why?
|
| Stimulation, Chemical | 2 | 1995 | 13 | 0.030 |
Why?
|
| Pyridones | 1 | 1995 | 9 | 0.030 |
Why?
|
| General Surgery | 1 | 1996 | 86 | 0.030 |
Why?
|
| Anticoagulants | 1 | 1997 | 136 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 9 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1996 | 163 | 0.030 |
Why?
|
| Diuresis | 1 | 1994 | 6 | 0.030 |
Why?
|
| Natriuresis | 1 | 1994 | 5 | 0.030 |
Why?
|
| Logistic Models | 1 | 1996 | 783 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1994 | 104 | 0.030 |
Why?
|
| Health Status | 1 | 1996 | 403 | 0.030 |
Why?
|
| Splenectomy | 1 | 1974 | 22 | 0.030 |
Why?
|
| Dogs | 3 | 1988 | 120 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 3708 | 0.020 |
Why?
|
| Ventricular Function, Left | 3 | 2006 | 268 | 0.020 |
Why?
|
| Ephedrine | 1 | 1992 | 3 | 0.020 |
Why?
|
| Shock | 1 | 1993 | 32 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 290 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1989 | 99 | 0.020 |
Why?
|
| Pulmonary Artery | 2 | 1992 | 26 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 97 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1991 | 14 | 0.020 |
Why?
|
| Nitroprusside | 1 | 1991 | 5 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 1991 | 16 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1991 | 31 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 47 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 308 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1990 | 1 | 0.020 |
Why?
|
| Protamines | 1 | 1990 | 4 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1991 | 96 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 51 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 109 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 162 | 0.020 |
Why?
|
| Lorazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Scopolamine | 1 | 1989 | 5 | 0.020 |
Why?
|
| Succinylcholine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Equipment Safety | 1 | 1989 | 19 | 0.020 |
Why?
|
| Halothane | 1 | 1988 | 1 | 0.020 |
Why?
|
| Verapamil | 1 | 1988 | 8 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1988 | 5 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 252 | 0.020 |
Why?
|
| Propranolol | 1 | 1988 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1991 | 894 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 381 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1988 | 72 | 0.020 |
Why?
|
| Edrophonium | 1 | 1987 | 1 | 0.020 |
Why?
|
| Isoflurane | 1 | 1987 | 1 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 7 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1987 | 18 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1987 | 24 | 0.020 |
Why?
|
| Catheterization | 1 | 1987 | 57 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1987 | 48 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1987 | 66 | 0.020 |
Why?
|
| Prognosis | 1 | 1991 | 1547 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2007 | 27 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1987 | 107 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 50 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 38 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 58 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2006 | 146 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1998 | 682 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1989 | 43 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 2287 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1992 | 421 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1999 | 123 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 363 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 193 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 821 | 0.010 |
Why?
|
| Milrinone | 1 | 1995 | 2 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1995 | 15 | 0.010 |
Why?
|
| Thyroxine | 1 | 1995 | 16 | 0.010 |
Why?
|
| Radioisotope Teletherapy | 1 | 1974 | 1 | 0.010 |
Why?
|
| Splenic Neoplasms | 1 | 1974 | 1 | 0.010 |
Why?
|
| Cobalt Radioisotopes | 1 | 1974 | 3 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1974 | 27 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1974 | 48 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1974 | 99 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1974 | 40 | 0.010 |
Why?
|
| Leukocytes | 1 | 1974 | 57 | 0.010 |
Why?
|
| Spleen | 1 | 1974 | 85 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1974 | 114 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 754 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1992 | 13 | 0.010 |
Why?
|
| Placebos | 1 | 1992 | 63 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1992 | 32 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 1992 | 19 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1992 | 102 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 23 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1991 | 1 | 0.010 |
Why?
|
| Magnesium | 1 | 1991 | 30 | 0.010 |
Why?
|
| Calcitriol | 1 | 1991 | 25 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 1610 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1988 | 2 | 0.000 |
Why?
|
| Vecuronium Bromide | 1 | 1987 | 1 | 0.000 |
Why?
|
| Pancuronium | 1 | 1987 | 2 | 0.000 |
Why?
|
| Nitrous Oxide | 1 | 1987 | 4 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 23 | 0.000 |
Why?
|
| Atropine | 1 | 1987 | 18 | 0.000 |
Why?
|
| Child | 1 | 1974 | 2478 | 0.000 |
Why?
|
| Probability | 1 | 1987 | 157 | 0.000 |
Why?
|
| Equipment Design | 1 | 1987 | 179 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1987 | 288 | 0.000 |
Why?
|
| Blood Pressure Determination | 1 | 1987 | 103 | 0.000 |
Why?
|
| Adolescent | 1 | 1974 | 3643 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1987 | 770 | 0.000 |
Why?
|